UK's Shield Diagnostics merges with Axis
This article was originally published in Clinica
Shield Diagnostics, a small UK diagnostics company which is developing alternative, possibly more accurate, diagnostic markers to cholesterol testing for cardiovascular disease prediction, has taken over its nearest rival, Axis Biochemicals.
You may also be interested in...
Under EU rules, once a medicinal product has been placed on the market in a country of the EEA – the EU plus Iceland, Liechtenstein and Norway
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.